There have been suggestions that corticosteroid treatment might improv
e bronchodilator responses in chronic obstructive pulmonary disease (C
OPD). We have studied bronchodilator responses to salbutamol and to ox
itropium bromide in 20 patients with stable moderate to severe COPD. D
ose responses to the two bronchodilators were tested before and after
3 week courses of placebo and 30 mg prednisolone. Thirteen patients we
re taking inhaled corticosteroids. There were no significant changes i
n numbers of responses or maximum bronchodilator effects from either b
ronchodilator, although there was a trend towards higher maximum level
s after 3 weeks of prednisolone. Spirometry measured at home each morn
ing before and after oxitropium bromide showed no difference between p
rednisolone and placebo periods. This study provides no evidence for a
significant effect on bronchodilator responses to beta-agonists or an
ticholinergic agents from 3 weeks of oral prednisolone in moderately s
evere COPD.